Yinfenidone Hydrochloride

盐酸伊非尼酮

Report date: 2026/05/18 20:02:07
NME

Base Information

Drug NameYinfenidone Hydrochloride
Drug Alias NameHEC-585HEC-00000585
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming growth factor beta 1 inhibitors
TargetsTransforming growth factor beta 1
Therapy Area/IndicationsIdiopathic Pulmonary FibrosisPulmonary FibrosisLung Diseases, Interstitial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesHec Pharm Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSunshine Lake Pharma Co LtdGuangdong Dongyangguang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary FibrosisPulmonary FibrosisLung Diseases, Interstitial
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A